5 completed, 1 withdrawn. 5 Phase 1, 1 Phase 2.
By phase and status
Follow DS-1971a: new trials by email Literature Review of DS-1971a trials Research Report on DS-1971a
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
DS-1971a, placebo, pregabalin - Neuropathic Pain, Diabetes | Phase 2 | Withdrawn | Daiichi Sankyo | | 2016-02-01 | 2016-07-27 |
Multiple Dose Study of D1971a in Healthy Volunteers
DS-1971a, Placebo - Healthy | Phase 1 | Completed | Daiichi Sankyo | 25 | 2015-09-01 | 2017-04-28 |
A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS
DS-1971a, midazolam hydrochloride, Omeprazole - Healthy | Phase 1 | Completed | Daiichi Sankyo | 18 | 2015-05-01 | 2015-11-05 |
Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets
DS-1971a suspension, DS-1971a tablet - Healthy | Phase 1 | Completed | Daiichi Sankyo | 18 | 2014-11-01 | 2018-12-24 |
Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971a
DS-1971a - Healthy | Phase 1 | Completed | Daiichi Sankyo | 48 | 2014-09-01 | 2018-12-24 |
Multiple Dose Study of DS-1971a
DS-1971a, placebo - Healthy | Phase 1 | Completed | Daiichi Sankyo | 32 | 2014-07-01 | 2018-12-24 |
Conditions studied
Diabetes Mellitus (1) · Hyperalgesia (1) · Neuralgia (1)
Sponsors
Daiichi Sankyo (6)
Countries
United Kingdom (5)
NIH funding
2015 (1)